{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:07:52Z","timestamp":1656720472666},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,2,20]],"date-time":"2010-02-20T00:00:00Z","timestamp":1266624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s12022-010-9110-2","type":"journal-article","created":{"date-parts":[[2010,2,19]],"date-time":"2010-02-19T04:40:10Z","timestamp":1266554410000},"page":"130-134","source":"Crossref","is-referenced-by-count":3,"title":["Somatostatin-Producing Atypical Null Cell Adenoma Manifesting as Severe Hypopituitarism and Rapid Deterioration\u2014Case Report"],"prefix":"10.1007","volume":"21","author":[{"given":"Yoshikazu","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiji","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,20]]},"reference":[{"key":"9110_CR1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/eje.1.02268","volume":"155","author":"M Kars","year":"2006","unstructured":"Kars M, Roelfsema F, Romijn JA, Pereira AM. Malignant prolactinoma: case report and review of the literature. Eur J Endocrinol 155:523-34, 2006.","journal-title":"Eur J Endocrinol"},{"key":"9110_CR2","doi-asserted-by":"crossref","unstructured":"Levy A, Hall L, Yeudall WA, Lightman SL. P53 gene mutations in pituitary adenomas: rare events. Clin Endocrinol (Oxf) 41:809-14, 1994.","DOI":"10.1111\/j.1365-2265.1994.tb02797.x"},{"key":"9110_CR3","first-page":"93","volume":"27","author":"M Mittelbronn","year":"2006","unstructured":"Mittelbronn M, Meyermann R, Honoegger J. Atypical pituitary adenoma exhibiting densely secretory granules and basophilia without hormone production. Neuro Endocrinol Lett 27:93-6, 2006.","journal-title":"Neuro Endocrinol Lett"},{"key":"9110_CR4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10\u00a0years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol 156:203-16, 2007.","journal-title":"Eur J Endocrinol"},{"key":"9110_CR5","first-page":"1066","volume":"56","author":"BW Scheithauer","year":"2005","unstructured":"Scheithauer BW, Kurtkaya-Yapicier O, Kovacs KT, Young WF Jr, Lloyd RV. Pituitary carcinoma: a clinicopathological review. Neurosurgery 56:1066-74, 2005.","journal-title":"Neurosurgery"},{"key":"9110_CR6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1227\/01.NEU.0000223437.51435.6E","volume":"59","author":"BW Scheithauer","year":"2006","unstructured":"Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, et al. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 59:341-53, 2006.","journal-title":"Neurosurgery"},{"key":"9110_CR7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00006123-199601000-00024","volume":"38","author":"K Thapar","year":"1996","unstructured":"Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38:99-107, 1996.","journal-title":"Neurosurgery"},{"key":"9110_CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11060-007-9492-2","volume":"87","author":"Y Ogawa","year":"2008","unstructured":"Ogawa Y, Tominaga T. A case of atypical thyrotroph cell adenoma, which re-grew within 3\u00a0months after surgery and required multimodal treatment. J Neurooncol 87:91-5, 2008.","journal-title":"J Neurooncol"},{"key":"9110_CR9","first-page":"10","volume-title":"Pituitary tumours: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C. eds. WHO classification of tumours. Pathology and genetics. Tumours of endocrine organs","author":"RV Lloyd","year":"2004","unstructured":"Lloyd RV, Kovacs K, Young WF Jr, et al. Pituitary tumours: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C, editors. WHO classification of tumours. Pathology and genetics. Tumours of endocrine organs. Lyon: IARC Press; 2004. p. 10\u20133."},{"key":"9110_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/ENDO:28:1:027","volume":"28","author":"G Kontogeorgos","year":"2005","unstructured":"Kontogeorgos G. Classification and pathology of pituitary tumors. Endocrine 28:27-35, 2005.","journal-title":"Endocr"},{"key":"9110_CR11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000095526","volume":"83","author":"G Kontogeorgos","year":"2006","unstructured":"Kontogeorgos G. Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83:179-88, 2006.","journal-title":"Neuroendocrinology"},{"key":"9110_CR12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1227\/00006123-199604000-00027","volume":"38","author":"K Thapar","year":"1996","unstructured":"Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr. P53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765-71, 1996.","journal-title":"Neurosurgery"},{"key":"9110_CR13","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1210\/jc.2004-2231","volume":"90","author":"GA Kaltsas","year":"2005","unstructured":"Kaltsas GA, Nomikos P, Kontogeorgos G, Buchfelder M, Grossman AB. Clinical review: diagnosis and management of pituitary carcinomas. J Clin Endocrinol Metab 90:3089-99, 2005.","journal-title":"J Clin Endocrinol Metab"},{"key":"9110_CR14","doi-asserted-by":"crossref","unstructured":"Mamelak AN, Carmichael JD, Park P, Bannykh S, Fan X, Bonert V. Atypical pituitary adenoma with malignant features. Pituitary Oct 24, 2008. Epub ahead of print.","DOI":"10.1007\/s11102-008-0151-1"},{"key":"9110_CR15","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03346512","volume":"32","author":"Y Ogawa","year":"2009","unstructured":"Ogawa Y, Ikeda H, Tominaga T. Clinicopathological study of prognostic factors in patients with pituitary adenomas and Ki-67 labeling index of more than 3%. J Endocrinol Invest 32:581-4, 2009.","journal-title":"J Endocrinol Invest"},{"key":"9110_CR16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s004010100413","volume":"102","author":"CH Rickert","year":"2001","unstructured":"Rickert CH, Scheithauer BW, Paulus W. Chromosomal aberrations in pituitary carcinoma metastasis. Acta Neuropathol 102:117-20, 2001.","journal-title":"Acta Neuropathol"},{"key":"9110_CR17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/jcp.55.2.148","volume":"55","author":"M Sironi","year":"2002","unstructured":"Sironi M, Cenacchi G, Cozzi L, Tonnarelli G, Iacobellis M, Trer\u00e8 D, Assi A. Progression on metastatic neuroendocrine carcinoma from a recurrent prolactinoma: a case report. J Clin Pathol 55:148-51, 2002.","journal-title":"J Clin Pathol"},{"key":"9110_CR18","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.4161\/cc.8.13.8785","volume":"8","author":"MM Ciulla","year":"2009","unstructured":"Ciulla MM, Acquistapace G, Toffetti L, Paliotti R, Ferrero S, Magrini F, Braidotti P. Ki67 cytoplasmic expression. Cell Cycle 8:2125, 2009.","journal-title":"Cell Cycle"},{"key":"9110_CR19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2559.2008.03191.x","volume":"54","author":"D Faatian","year":"2008","unstructured":"Faatian D, Munro A, Twelves C, Bartlett JMS. Membranous and cytoplasmic staining of Ki-67 is associated with HER2 and ER status in invasive breast carcinoma. Histophthology 54:254-257, 2008.","journal-title":"Histophthology"},{"key":"9110_CR20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00000478-200004000-00013","volume":"24","author":"M Hirokawa","year":"2000","unstructured":"Hirokawa M, Carney JA. Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid glands. Am J Surg Pathol 24:575-578, 2000.","journal-title":"Am J Surg Pathol"},{"key":"9110_CR21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2559.2002.01330.x","volume":"40","author":"H Hattori","year":"2002","unstructured":"Hattori H. Sclerosing haemangioma of the lung is positive for MIB-1 in cell membrane and cytoplasmic staining pattern. Histopathology 40:291-293, 2002.","journal-title":"Histopathology"},{"key":"9110_CR22","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1046\/j.1365-2559.2002.01457_1.x","volume":"41","author":"T Tashiro","year":"2002","unstructured":"Tashiro T, Hirokawa M, Harada H, Yokoyama S, Sano T. Cell membrane expression of MIB-1 in salivary gland pleomorphic adenoma. Histopathology 41:559-561, 2002.","journal-title":"Histopathology"},{"key":"9110_CR23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1210\/jcem-68-3-572","volume":"68","author":"D Joubert","year":"1989","unstructured":"Joubert D, Benlot C, Lagoguey A, Garnier P, Brandi AM, Gautron JP, et al. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone. J Clin Endocrinol Metab 68:572-7, 1989.","journal-title":"J Clin Endocrinol Metab"},{"key":"9110_CR24","unstructured":"Peillon F, Le Dafniet M, Garnier P, Feinstein MC, Donnadieu M, Barret A, et al. Neurohormones provenant de L\u2019ant\u00e8hypophyse humaine normale et tumorale s\u00e8cr\u00e8tion et r\u00e8gulation in vitro. Pathol Biol (Paris) 37:840-5, 1989."},{"key":"9110_CR25","first-page":"161","volume":"306","author":"F Peillon","year":"1988","unstructured":"Peillon F, Liappi G, Garnier P, Brandi AM, Evan-Brion D, Dodeur M, et al. S\u00e8cr\u00e8tion in vitro de somatostaine (SRIH) par les cellules somatotropes ad\u00e8nomateuses humaines. Relation avec la lib\u00e8ration d\u2019hormone somatotrope (GH) et modulation par la thyrolib\u00e8rine (TRH). C R Acad Sci III 306:161-6, 1988.","journal-title":"C R Acad Sci III"},{"key":"9110_CR26","doi-asserted-by":"crossref","unstructured":"Pawlikowski M, Pisarek H, Kunert-Radek J, Radek A. Immunohistochemical detection of somatostatin receptor subtypes in \u201cclinically nonfunctioning\u201d pituitary adenomas. Endocr Pathol 14:231-8, 2003.","DOI":"10.1007\/s12022-003-0015-1"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-010-9110-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-010-9110-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-010-9110-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:01:02Z","timestamp":1559440862000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-010-9110-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,20]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9110"],"URL":"https:\/\/doi.org\/10.1007\/s12022-010-9110-2","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,20]]}}}